| Influvac 0.5 ml, Injektionssuspension in einer Fertigspritze - 10 | | 69992002 | | Viatris Pharma GmbH | | Influvac 0.5 ml, Injektionssuspension in einer Fertigspritze | | 27.10.2025 | | | | | 27.10.2025 | | Influenza, gereinigtes Antigen (J07BB02) | | | | WHO-DDD | | 26.10.2030 | | | | 10 | | 08.08. | | | | | | | | Nein | | | | | | | | | | | | k.A. | | | | FB | | | | 7680699920020 | | Impfstoffe | | | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Victoria/4897/2022 (H1N1)-pdm09: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Darwin/9/2021 (H3N2)-like: reassortant virus SAN-010 derived from A/Darwin/9/2021) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant virus BVR-26 derived from B/Austria/1359417) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2 mg, kalium 0.08 mg, residui: natrii citras dihydricus, saccharum, cetrimidum, formaldehydum, gentamicini sulfas, tylosini tartras, hydrocortisonum, polysorbatum 80, ovalbuminum. | | Packungsbestandteile | | | | Quelle | | | |
|
|
